Home › Chronic Lymphocytic Leukemia › Michigan › Canton
Chronic Lymphocytic Leukemia clinical trials in Canton, MI
3 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Canton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH29 studies
- Durham, NC28 studies
- Washington, DC22 studies
- Seattle, WA22 studies
- Rochester, MN20 studies
- New York City, NY20 studies
- Houston, TX18 studies
- Baldwin Park, CA18 studies
- Cincinnati, OH15 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
Other studies in Canton
- Lung Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Colorectal Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Ovarian Cancer4 studies
- Bladder Cancer4 studies
- Breast Cancer4 studies
- Pancreatic Cancer3 studies
- Esophageal Cancer3 studies
- Stomach Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.